Conference abstract · 24 Aug 2015
CommentaryPublished 2013
Engineering Anti-Tumor T Cell Immunity
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
T cell immunity is critical for protection against infectious agents as well as cancer. T cell immune response is a well orchestrated process that involves three key components. CD8+ T cells that harbor cytolytic machinery and can target and kill the tumor cells in an antigen specific manner, CD4+ T cells that can either “help” the generation of a productive CD8+ T cell or “regulate/suppress” it, and the Antigen Presenting Cells (APC) that can efficiently process the antigens and present them to the effector T cells in small fragments, termed as the antigenic epitopes. The specificity and efficacy of T cell immune response is evident by the remarkable success of vaccines against infectious agents. However, attempts to develop similar approaches against cancer have not resulted in similar success. The main reason for this is the fact that, most human cancers arise from within and self-reactive immune repertoire is eliminated during developmental process to prevent autoimmunity.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Engineered erythrocytes as an anti-tumor therapy through induction of apoptosis or immune-checkpoint inhibition
Short communication · 25 Sep 2023
Immune cell-mediated anti-tumor actions when c-myb-selective antisense oligonucleotides are embedded in anti-GD2 immunoliposomes.
Commentary · 13 May 2022
Amplify Immunogenic Cell Death for Anti-Tumor Immunotherapy
Conference abstract
Tumor necrosis factor-and#945;/CD40 ligand-engineered mesenchymal stem cells: Towards the development of a new anti-cancer vaccine
More from this journal
The newest in Advancements in Genetic Engineering.
Commentary · 1 Jul 2026
Genetic Engineering in Enhancing Human Muscle Regeneration for Degenerative Muscle Disorders
Commentary · 1 Jul 2026
Genetic Engineering in Engineering Human Liver Detoxification Pathways for Chronic Toxic Load Disorders
Perspective · 1 Jul 2026
Genetic Engineering in Developing Synthetic Neural Circuits for Cognitive Function Restoration
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAdvancements in Genetic Engineering
- SubjectGenetics & Molecular Biology
- SubjectEngineering
- BylineArticles whose byline prints “Arvind Chhabra”

